trending Market Intelligence /marketintelligence/en/news-insights/trending/_46Kik-F1qzG-YvtMpq3BQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Riverside invests in Spanish pharmaceutical ingredient maker

Street Talk Episode 56 - Latest bank MOE shows even the strong need scale to thrive

South State CenterState MOE Shows Even The Strong Need Scale To Thrive

Talking Bank Stocks, Playing The M&A Trade With Longtime Investor

Report: Kashkari Says Fed In Holding Pattern But Rate Cut Still Possible

Riverside invests in Spanish pharmaceutical ingredient maker

Lower-middle-market private equity firm Riverside Partners LLC, doing business as The Riverside Co., made an undisclosed investment in Spanish active pharmaceutical ingredients producer HealthTech BioActives SL.

The transaction includes the 140 employees of HealthTech, which is a carve-out of Spain-based international pharmaceutical company Ferrer.

KPMG was carve-out and financial adviser to Riverside, with Garrigues and Advocatenkantoor Parmentier offering legal and tax counsel. A&O was a legal adviser for the financing process, while Dextra Corporate was the exclusive buy-side M&A adviser, and PWC was ESG and buy-side debt adviser. Roland Berger was commercial adviser, and financing was provided by LGT Private Debt.

Deloitte was Ferrer's financial, legal, tax and exclusive sell-side M&A adviser.